Skip Navigation

European Journal of Heart Failure 2008 10(3):291-297; doi:10.1016/j.ejheart.2008.02.006
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Milliez, P.
Right arrow Articles by Leenhardt, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milliez, P.
Right arrow Articles by Leenhardt, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 European Society of Cardiology

Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: Results from a short and mid-term study

Paul Millieza,*,1, Olivier Thomasb,1, Abdeddayem Hagguia, Patrick Schurandoc, Pierre Squarab, Alain Cohen-Solala, Alexandre Mebazaac and Antoine Leenhardta

a AP-HP, Department of Cardiology, Lariboisiere Hospital, Denis Diderot University Paris, France
b Department of Cardiology, Ambroise Pare Clinic Neuilly sur Seine, France
c AP-HP, Department of Anesthesiology, Lariboisiere Hospital, Denis Diderot University Paris, France

* Corresponding author. Cardiology Department, Lariboisiere Hospital, 2, rue Ambroise Pare 75010 Paris, France. Tel.: +33 1 49958223; fax: +33 1 49958439. E-mail address: paulmilliez{at}hotmail.com (P. Milliez).


   Abstract

Background: Cardiac resynchronisation therapy (CRT) is a validated treatment for heart failure (HF) patients in NYHA class III–IV despite optimal medical therapy. We aimed to assess the beneficial effects of CRT in patients with catecholamine-dependent overt HF (CDOHF).

Methods: We studied 20 CDOHF patients who had undergone CRT implantation. Patients had a mean baseline QRS duration of 174–25 ms and/or echocardiographic asynchrony, and LVEF of 18–3%. Mean follow-up was 18–12 months. Dependence on catecholamine agents was defined as the inability to stop or reduce drug infusion without re-occurrence of hypotension, low urine output and hypoxaemia.

Results: After CRT implantation, catecholamine agents were mostly withdrawn within 2days and blood pressure, urine output and BNP rapidly improved within 24h. During follow-up, survival rates were 85% at 3months, 80% at 6months and 55% at 18 months. Among the 9 deaths, 5 were related to overt HF, 3 to sudden cardiac death and 1 to non-cardiac death. LVEF improved from 18±3% to 21±4% three months after CRT implantation.

Conclusion: "Rescue" CRT implantation in CDOHF patients allowed a rapid and successful catecholamine weaning in all studied patients. Furthermore, this immediate beneficial effect is sustained for more than one year in surviving patients.

Key Words: CRT • Rescue • Acute decompensated heart failure

Received August 7, 2007; Revised December 21, 2007; Accepted February 7, 2008


1 Paul Milliez and Olivier Thomas equally contributed to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
E. Huvelle, R. Fay, F. Alla, A. Cohen Solal, A. Mebazaa, and F. Zannad
Left bundle branch block and mortality in patients with acute heart failure syndrome: a substudy of the EFICA cohort
Eur J Heart Fail, February 1, 2010; 12(2): 156 - 163.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
F. Braunschweig and P. J. Hauptman
Cardiac resynchronization therapy in the intensive care setting; the promise and peril of using implantable devices off label
Eur J Heart Fail, March 1, 2008; 10(3): 220 - 221.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.